Cervical cancer affects the cells of the cervix, which is the bottom portion of the uterus. There have been several recent research approaches to cervical cancer, including: Human papillomavirus (HPV) is a common sexually transmitted infection that can cause cervical cancer. HPV vaccines can prevent infection with certain strains of the virus and have been shown to be highly effective in preventing cervical cancer.
Liquid biopsy is a non-invasive test that analyzes blood or other bodily fluids to detect cancer or other diseases. Recent research has shown that liquid biopsy can be used to detect early-stage cervical cancer and monitor disease progression. Immunotherapy involves using the body's immune system to fight cancer. Recent research has focused on using immunotherapy to treat cervical cancer, including the development of vaccines that target cancer-specific antigens.
Precision medicine involves tailoring treatment to the individual characteristics of each patient, including their genetics, lifestyle, and environment. Recent research has shown that precision medicine can improve the accuracy of diagnosis and lead to better outcomes for patients with cervical cancer. Regular screening for cervical cancer, such as Pap tests and HPV testing, can detect abnormal cells before they become cancerous. Recent research has focused on improving the accuracy of screening tests and increasing access to screening for underserved populations.
- Gynecologic Oncology
- Radiation Oncology
- Surgical Oncology
- Medical Oncology
- Reproductive Health